SecuritySEAC / SeaChange International, Inc. (811699107)
IndustryRadio and Television Broadcasting and Communications Equipment
Institutional Owners67
Institutional Shares26,755,172 - 74.84%
Common Shares Outstanding35,749,131 shares (as of 2018-07-31)
Institutional Value$ 90,535,000 USD

Institutional Stock Ownership and Shareholders

SEAC / SeaChange International, Inc. Institutional Ownership

SeaChange International, Inc. (NASDAQ:SEAC) has 67 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 26,755,172 shares. Largest shareholders include Ariel Investments, Llc, Dimensional Fund Advisors Lp, Neuberger Berman Group LLC, Renaissance Technologies LLC, Segall Bryant & Hamill, Llc, Vanguard Group Inc, PenderFund Capital Management Ltd., Royce & Associates LLC, Algert Global Llc, and Connors Investor Services Inc.
SeaChange International, Inc. (NASDAQ:SEAC) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-07-17 13F-HR PenderFund Capital Management Ltd. 1,437,584 1,441,722 0.29 4,572,000 6,252 -99.86
2018-08-02 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 19,500 19,500 0.00 53 67 26.42
2018-08-10 13F-HR ARIEL INVESTMENTS, LLC 2,583,823 3,417,075 32.25 7,002 11,686 66.90
2018-08-13 13F-HR PRUDENTIAL FINANCIAL INC 65,700 88,700 35.01 178 304 70.79
2018-08-03 13F-HR SEI INVESTMENTS CO 11,970 9,516 -20.50 32 32 0.00
2018-08-14 13F-HR G2 Investment Partners Management LLC 214,170 0 -100.00 580 0 -100.00
2018-07-30 13F-HR Penbrook Management LLC 36,500 36,300 -0.55 99 124 25.25
2018-07-11 13F-HR Vigilant Capital Management, LLC 25,000 25,000 0.00 68 86 26.47
2018-08-14 13F-HR ZACKS INVESTMENT MANAGEMENT 25,451 0 -100.00 69 0 -100.00
2018-08-01 13F-HR ALGERT GLOBAL LLC 1,043,648 967,909 -7.26 2,828 3,310 17.04
2018-07-24 13F-HR ACADIAN ASSET MANAGEMENT LLC 95,134 285,437 200.04 257 976 279.77
2018-08-15 13F-HR/A GMT Capital Corp 38,180 38,180 0.00 103 131 27.18
2018-08-08 13F-HR SEGALL BRYANT & HAMILL, LLC 1,840,967 1,929,113 4.79 4,989 6,598 32.25
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 12,304 0 -100.00 33 0 -100.00
2017-02-10 13F-HR BlackRock Investment Management, LLC 6,043 6,043 0.00 18 14 -22.22
2018-09-18 13F-HR/A NORTHERN TRUST CORP 108,949 109,149 0.18 296 373 26.01
2018-08-14 13F-HR VANGUARD GROUP INC 1,839,094 1,764,336 -4.06 4,984 6,034 21.07
2018-08-14 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 2,436 0 -100.00 7 0 -100.00
2018-08-14 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 149,608 153,408 2.54 405 525 29.63
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 77 77 0.00 0 0
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 33,398 33,078 -0.96 91 113 24.18
2018-08-14 13F-HR DSC Advisors, L.P. 370,000 400,000 8.11 1,003 1,368 36.39
2018-08-10 13F-HR FEDERATED INVESTORS INC /PA/ 1,104 1,104 0.00 3 4 33.33
2017-02-10 13F-HR BlackRock Fund Advisors 93,124 96,158 3.26 278 221 -20.50
2018-08-03 13F-HR Engineers Gate Manager LP 16,312 0 -100.00 44 0 -100.00
2018-08-14 13F-HR Dynamic Technology Lab Private Ltd 13,756 0 -100.00 37 0 -100.00
2018-07-20 13F-HR Steward Partners Investment Advisory, Llc 35,752 35,752 0.00 96 122 27.08
2018-08-13 13F-HR Axa 165,303 165,303 0.00 448 565 26.12
2018-08-13 13F-HR Renaissance Technologies LLC 2,066,992 5,602
2018-08-13 13F-HR CONNORS INVESTOR SERVICES INC 626,228 836,454 33.57 1,697 2,861 68.59
2018-08-13 13F-HR OXFORD ASSET MANAGEMENT 19,624 168,727 759.80 53 572 979.25
2018-08-14 13F-HR STATE STREET CORP 42,401 42,401 0.00 115 146 26.96
2018-08-14 13F-HR PANAGORA ASSET MANAGEMENT INC 17,732 17,732 0.00 48 61 27.08
2018-08-09 13F-HR Royce & Associates LLC 1,590,544 1,382,675 -13.07 4,310 4,729 9.72
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 180,000 180,000 0.00 488 616 26.23
2018-08-10 13F-HR ClariVest Asset Management LLC 66,197 66,197 0.00 180 226 25.56
2018-08-08 13F-HR BRONFMAN E.L. ROTHSCHILD, L.P. 477 0 -100.00 1 0 -100.00
2018-08-14 13F-HR MORGAN STANLEY 23,800 30,631 28.70 65 105 61.54
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 610,621 610,621 0.00 1,826 1,404 -23.11
2018-07-24 13F-HR Eidelman Virant Capital 242,000 220,000 -9.09 655 752 14.81
2018-08-13 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 11,431 0 -100.00 31 0 -100.00
2018-08-13 13F-HR AJO, LP 275,252 941
2018-08-14 13F-HR Alambic Investment Management, L.P. 710,353 470,485 -33.77 1,925 1,609 -16.42
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 370,172 245,825 -33.59 1,002 840 -16.17
2018-08-14 13F-HR DEUTSCHE BANK AG\ 383,213 331,782 -13.42 1,038 1,134 9.25
2018-08-08 13F-HR PINNACLE ASSOCIATES LTD 19,400 19,400 0.00 53 66 24.53
2018-08-14 13F-HR MILLENNIUM MANAGEMENT LLC 202,791 261,433 28.92 550 894 62.55
2018-08-08 13F-HR Spark Investment Management LLC 84,600 128,000 51.30 229 437 90.83
2018-08-09 13F-HR BlackRock Inc. 659,504 661,537 0.31 1,787 2,263 26.64
2018-04-18 13F-HR/A FNY Partners Fund LP 74,175 13,040 -82.42 291 35 -87.97
2018-08-13 13F-HR Neuberger Berman Group LLC 2,143,263 2,097,883 -2.12 5,808 7,174 23.52
2018-08-14 13F-HR Brandywine Global Investment Management, LLC 0 12,240 0 42
2018-08-08 13F-HR Russell Investments Group, Ltd. 37,900 543,025 1,332.78 103 1,858 1,703.88
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 289,928 385,107 32.83 786 1,317 67.56
2018-08-14 13F-HR UBS Group AG 320 1,042 225.62 1 4 300.00
2018-08-14 13F-HR AMERIPRISE FINANCIAL INC 667,063 667,063 0.00 1,808 2,281 26.16
2018-08-14 13F-HR MACQUARIE GROUP LTD 263,052 208,652 -20.68 713 714 0.14
2018-08-14 13F-HR ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 147,460 161,773 9.71 400 553 38.25
2018-07-23 13F-HR CAPROCK Group, Inc. 32,325 29,860 -7.63 88 102 15.91
2018-08-14 13F-HR JP Morgan Chase & Co 253,888 169,231 -33.34 688 579 -15.84
2018-08-14 13F-HR Hilltop Holdings Inc. 75,065 257
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 2,129,476 2,256,002 5.94 5,771 7,715 33.69
2018-08-14 13F-HR Squarepoint Ops LLC 70,100 27,800 -60.34 190 95 -50.00
2018-08-14 13F-HR TWO SIGMA ADVISERS, LP 208,908 169,570 -18.83 566 580 2.47
2018-08-13 13F-HR Allianz Asset Management AG 32,325 29,860 -7.63 88 102 15.91
2018-08-13 13F-HR Weiss Asset Management LP 17,473 0 -100.00 47 0 -100.00
2018-08-14 13F-HR BARCLAYS PLC 2 0 -100.00 0 0
2018-08-14 13F-HR MANAGED ASSET PORTFOLIOS, LLC 52,800 58,300 10.42 143 199 39.16
2018-08-14 13F-HR GOLDMAN SACHS GROUP INC 184,713 0 -100.00 501 0 -100.00
2018-08-13 13F-HR Hillsdale Investment Management Inc. 373,200 0 -100.00 1,011 0 -100.00
2018-08-14 13F-HR A.R.T. Advisors, LLC 72,071 0 -100.00 195 0 -100.00
2018-08-07 13F-HR FULLER & THALER ASSET MANAGEMENT, INC. 518,300 0 -100.00 1,405 0 -100.00
2018-08-14 13F-HR Adirondack Research & Management Inc. 167,498 167,498 0.00 454 573 26.21
2017-02-10 13F-HR BlackRock Advisors LLC 7,106 7,106 0.00 21 16 -23.81
2018-08-01 13F-HR Connor, Clark & Lunn Investment Management Ltd. 0 31,182 0 107
2018-08-03 13F-HR EAM Investors, LLC 140,809 0 -100.00 382 0 -100.00
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 146,643 150,437 2.59 397 514 29.47
2018-08-14 13F-HR TWO SIGMA INVESTMENTS LLC 332,979 215,907 -35.16 902 738 -18.18
2018-08-10 13F-HR Ancora Advisors, LLC 49,954 171
2018-08-13 13F-HR RMB Capital Management, LLC 30,600 30,600 0.00 83 105 26.51
2018-08-10 13F-HR PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 30,000 30,000 0.00 81 103 27.16
2018-07-19 13F-HR BOURGEON CAPITAL MANAGEMENT LLC 136,338 127,971 -6.14 369 438 18.70

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Related News Stories

SeaChange International, Inc. (SEAC) CEO Ed Terino on Q2 2019 Results - Earnings Call Transcript

2018-09-06 seekingalpha
Greetings and welcome to SeaChange International's Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Mary Conway, Investor Relations. (4-2)

Is Knoll (KNL) Stock Undervalued Right Now?

2018-08-30 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. (6-0)

Are Investors Undervaluing Condor Hospitality (CDOR) Right Now?

2018-08-30 zacks
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. (6-0)

Should Value Investors Buy OFG Bancorp (OFG) Stock?

2018-08-30 zacks
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. (6-0)

Is XCel Brands (XELB) a Great Value Stock Right Now?

2018-08-30 zacks
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. (7-0)

CUSIP: 811699107